US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OKYO Pharma Limited

1.50

-0.0400-2.60%

Post-market: 1.48-0.0187-1.25%17:51 EDT

Volume:38.55K

Turnover:58.87K

Market Cap:78.72M

PE:-6.25

High:1.56

Open:1.55

Low:1.49

Close:1.54

52wk High:3.20

52wk Low:1.34

Shares:52.48M

Float Shares:28.04M

Volume Ratio:0.55

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2400

EPS(LYR):-0.2400

ROE:-263.78%

ROA:-43.09%

PB:6.38

PE(LYR):-6.25

Loading ...

Overview Company News Filings

Okyo Pharma receives feedback from FDA Type D meeting on urcosimod pathway

OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain

OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium

OKYO Pharma files Form 3 initial beneficial ownership for CMO Flavio Mantelli

OKYO Pharma files Form 3 as director Bernard Denoyer reports beneficial ownership holdings

OKYO Pharma files Form 3 for director John P. Brancaccio initial beneficial ownership statement

OKYO Pharma files Form 3 for CEO, director Robert Dempsey beneficial ownership statement

OKYO Pharma Adds European Eye Disease Expert to Advisory Board as Urcosimod Advances in Neuropathic Corneal Pain

OKYO Pharma appoints Marta Sacchetti to scientific advisory board

Press Release: OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD

OKYO Pharma CEO to present at Eyecelerator conference

OKYO Pharma to Showcase Urcosimod Data and Convene Key Advisory Board at 2026 ASCRS Meeting

OKYO Pharma plans new urcosimod trial for neuropathic corneal pain in H1 2026

OKYO Pharma Director Boosts Stake as Lead Eye-Pain Drug Advances Toward Phase 2b/3

OKYO Pharma director John Brancaccio buys 5,000 shares at USD 1.61

Okyo Pharma CDO, director acquire shares

OKYO Pharma Announces Chief Development Officer and Director Acquires Shares

OKYO Pharma Chief Development Officer Gary S. Jacob files Form 3 initial beneficial ownership statement

OKYO Pharma Director and 10% Owner Gabriele M Cerrone Files Initial Beneficial Ownership Statement

Okyo Pharma reports results from Phase 2a trial of urcosimod

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/OKYO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OKYO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OKYO\",,,,,undefined,":{"symbol":"OKYO","market":"US","secType":"STK","nameCN":"OKYO Pharma Limited","latestPrice":1.5,"timestamp":1787601600000,"preClose":1.54,"halted":0,"volume":38552,"hourTrading":{"tag":"盘后","latestPrice":1.4813,"preClose":1.5,"latestTime":"17:51 EDT","volume":201,"amount":300.63,"timestamp":1787608319797,"change":-0.0187,"changeRate":-0.012467,"amplitude":0.019133},"delay":0,"changeRate":-0.025974025974025997,"floatShares":28039400,"shares":52479300,"eps":-0.24,"marketStatus":"Closed","change":-0.04,"latestTime":"08-24 16:00:00 EDT","open":1.55,"high":1.56,"low":1.49,"amount":58874.432356799996,"amplitude":0.045455,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.24,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"adrRate":65,"listingDate":1652760000000,"exchange":"NASDAQ","adjPreClose":1.54,"postHourTrading":{"tag":"盘后","latestPrice":1.4813,"preClose":1.5,"latestTime":"17:51 EDT","volume":201,"amount":300.63,"timestamp":1787608319797,"change":-0.0187,"changeRate":-0.012467,"amplitude":0.019133},"volumeRatio":0.546053},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OKYO\",,,,,undefined,":{"symbol":"OKYO","floatShares":28039400,"roa":"-43.09%","roe":"-263.78%","lyrEps":-0.24,"volumeRatio":0.546053,"shares":52479300,"dividePrice":0,"high":1.56,"amplitude":0.045455,"preClose":1.54,"low":1.49,"week52Low":1.3401,"pbRate":"6.38","week52High":3.2,"institutionHeld":0,"latestPrice":1.5,"eps":-0.24,"divideRate":0,"volume":38552,"delay":0,"ttmEps":-0.24,"open":1.55,"prevYearClose":2.07,"prevWeekClose":1.54,"prevMonthClose":1.68,"prevQuarterClose":1.5,"fiveDayClose":1.52,"twentyDayClose":1.64,"sixtyDayClose":1.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OKYO\",params:#limit:5,,,undefined,":[{"date":"2026-07-20","symbol":"OKYO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1784534400000,"name":null,"time":"Pre-MKt","dateTimestamp":1784520000000,"actualEps":null},{"market":"US","date":"2025-07-18","symbol":"OKYO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1752811200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-15","symbol":"OKYO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1692072000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-12-30","symbol":"OKYO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1672376400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-08-16","symbol":"OKYO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1660622400000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OKYO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OKYO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1787284800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OKYO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OKYO","date":"2026-08-21","current":-6.291667,"percent":0.5,"low":-330.07601,"twenty":-18.428379,"median":-8.913066,"eighty":-3.505996,"high":-0.078124,"avg":-10.915687,"sd":11.978386,"marketCap":79768881},"quantilePoints":[{"date":"2021-08-27","current":-18.55601,"twenty":-25.292302,"median":-3.824632,"eighty":-1.711221,"marketCap":65381342.44},{"date":"2021-09-03","current":-18.366663,"twenty":-25.090766,"median":-3.824632,"eighty":-1.808431,"marketCap":65271363.01},{"date":"2021-09-10","current":-17.419928,"twenty":-25.052815,"median":-3.859151,"eighty":-1.843696,"marketCap":61833132.54},{"date":"2021-09-17","current":-17.041234,"twenty":-25.052815,"median":-3.859151,"eighty":-1.925002,"marketCap":60077948.48},{"date":"2021-09-24","current":-16.567866,"twenty":-25.052815,"median":-3.89159,"eighty":-1.972831,"marketCap":58052214.51},{"date":"2021-10-01","current":-15.621131,"twenty":-25.052815,"median":-3.920248,"eighty":-1.972831,"marketCap":54244802.55},{"date":"2021-10-08","current":-17.419928,"twenty":-24.85503,"median":-4.015864,"eighty":-1.972831,"marketCap":60895410.84},{"date":"2021-10-15","current":-18.55601,"twenty":-24.683616,"median":-4.045884,"eighty":-1.972831,"marketCap":65453320.58},{"date":"2021-10-22","current":-23.66838,"twenty":-24.499016,"median":-4.111479,"eighty":-1.972831,"marketCap":83511660.66},{"date":"2021-10-29","current":-22.267212,"twenty":-24.39353,"median":-4.111479,"eighty":-1.972831,"marketCap":78114007.5},{"date":"2021-11-05","current":-20.638827,"twenty":-24.214521,"median":-4.111479,"eighty":-1.972831,"marketCap":71363386.44},{"date":"2021-11-12","current":-23.289686,"twenty":-23.87862,"median":-4.232617,"eighty":-1.972831,"marketCap":80074572.11},{"date":"2021-11-19","current":-25.59972,"twenty":-24.683616,"median":-4.302711,"eighty":-1.972831,"marketCap":88354693.2},{"date":"2021-11-26","current":-26.319239,"twenty":-25.052815,"median":-4.302711,"eighty":-1.972831,"marketCap":89842434.41},{"date":"2021-12-03","current":-27.644668,"twenty":-25.218806,"median":-4.302711,"eighty":-1.972831,"marketCap":93693091.37},{"date":"2021-12-10","current":-26.508586,"twenty":-25.561851,"median":-4.421545,"eighty":-1.972831,"marketCap":89917592.34},{"date":"2021-12-17","current":-27.455321,"twenty":-25.909885,"median":-4.493943,"eighty":-1.972831,"marketCap":93395896.54},{"date":"2021-12-23","current":-27.076627,"twenty":-26.360956,"median":-4.493943,"eighty":-1.972831,"marketCap":93019964.62},{"date":"2021-12-31","current":-27.076627,"twenty":-26.484861,"median":-4.493943,"eighty":-1.972831,"marketCap":93977219.3},{"date":"2022-01-07","current":-26.129892,"twenty":-26.662539,"median":-4.613438,"eighty":-1.972831,"marketCap":90889445.12},{"date":"2022-01-14","current":-26.129892,"twenty":-26.484861,"median":-4.828664,"eighty":-1.974266,"marketCap":91585430.26},{"date":"2022-01-21","current":-25.183157,"twenty":-26.389961,"median":-4.876406,"eighty":-1.980005,"marketCap":87525085.76},{"date":"2022-01-28","current":-13.024565,"twenty":-26.371385,"median":-4.972021,"eighty":-2.008701,"marketCap":68418747.65},{"date":"2022-02-04","current":-11.78413,"twenty":-26.371385,"median":-4.984427,"eighty":-2.008701,"marketCap":62465405.82},{"date":"2022-02-11","current":-12.900522,"twenty":-26.371385,"median":-4.984427,"eighty":-2.037396,"marketCap":68643570.91},{"date":"2022-02-18","current":-19.846956,"twenty":-26.371385,"median":-5.258869,"eighty":-2.037396,"marketCap":105517960.7},{"date":"2022-02-25","current":-26.345185,"twenty":-26.3751,"median":-5.294562,"eighty":-2.037396,"marketCap":138233083.01},{"date":"2022-03-04","current":-26.345185,"twenty":-26.902555,"median":-5.330256,"eighty":-2.037396,"marketCap":136218215.22},{"date":"2022-03-11","current":-24.588839,"twenty":-26.902555,"median":-5.330256,"eighty":-2.037396,"marketCap":125626290.43},{"date":"2022-03-18","current":-24.588839,"twenty":-26.902555,"median":-5.330256,"eighty":-2.037396,"marketCap":126770123.33},{"date":"2022-03-25","current":-24.588839,"twenty":-26.902555,"median":-5.330256,"eighty":-2.04457,"marketCap":126880465.8},{"date":"2022-04-01","current":-21.954321,"twenty":-26.902555,"median":-5.330256,"eighty":-2.04457,"marketCap":112591214.25},{"date":"2022-04-08","current":-21.515234,"twenty":-26.902555,"median":-5.517017,"eighty":-2.04457,"marketCap":109576744.55},{"date":"2022-04-14","current":-21.515234,"twenty":-26.902555,"median":-5.840704,"eighty":-2.04457,"marketCap":109943102.3},{"date":"2022-04-22","current":-21.515234,"twenty":-26.902555,"median":-5.975988,"eighty":-2.04457,"marketCap":108163196.24},{"date":"2022-04-29","current":-21.515234,"twenty":-26.902555,"median":-5.975988,"eighty":-2.062505,"marketCap":105671738.8},{"date":"2022-05-06","current":-21.515234,"twenty":-26.902555,"median":-6.215027,"eighty":-2.068244,"marketCap":104095874.86},{"date":"2022-05-13","current":-20.637062,"twenty":-26.902555,"median":-6.215027,"eighty":-2.068244,"marketCap":98795219.68},{"date":"2022-05-20","current":-15.76814,"twenty":-26.902555,"median":-6.603097,"eighty":-2.068244,"marketCap":76903414.15},{"date":"2022-05-27","current":-9.945501,"twenty":-26.902555,"median":-7.171185,"eighty":-2.11387,"marketCap":49089341.63},{"date":"2022-06-03","current":-9.945501,"twenty":-26.902555,"median":-7.171185,"eighty":-2.151462,"marketCap":48671826.49},{"date":"2022-06-10","current":-9.945501,"twenty":-26.902555,"median":-7.171185,"eighty":-2.152179,"marketCap":47937926.7},{"date":"2022-06-17","current":-10.487983,"twenty":-26.902555,"median":-7.171185,"eighty":-2.152179,"marketCap":50095430.69},{"date":"2022-06-24","current":-10.487983,"twenty":-26.91783,"median":-7.171185,"eighty":-2.152179,"marketCap":50435914.36},{"date":"2022-07-01","current":-9.945501,"twenty":-26.91783,"median":-7.888304,"eighty":-2.152179,"marketCap":46813367.82},{"date":"2022-07-08","current":-9.945501,"twenty":-26.91783,"median":-7.888304,"eighty":-2.152179,"marketCap":46829141.85},{"date":"2022-07-15","current":-9.945501,"twenty":-26.91783,"median":-8.127343,"eighty":-2.152179,"marketCap":46190456.52},{"date":"2022-07-22","current":-9.945501,"twenty":-26.91783,"median":-8.605422,"eighty":-2.152179,"marketCap":46795916.11},{"date":"2022-07-29","current":-9.945501,"twenty":-26.91783,"median":-8.605422,"eighty":-2.154331,"marketCap":47347648.65},{"date":"2022-08-05","current":-9.945501,"twenty":-26.91783,"median":-8.89227,"eighty":-2.154331,"marketCap":46870881.56},{"date":"2022-08-12","current":-9.945501,"twenty":-26.91783,"median":-9.083501,"eighty":-2.154331,"marketCap":47174876.35},{"date":"2022-08-19","current":-9.78603,"twenty":-26.91783,"median":-9.403019,"eighty":-2.155766,"marketCap":45966750.14},{"date":"2022-08-26","current":-9.074319,"twenty":-26.91783,"median":-9.430175,"eighty":-2.292788,"marketCap":42504218.2},{"date":"2022-09-02","current":-11.565309,"twenty":-26.91783,"median":-9.78603,"eighty":-2.390395,"marketCap":53230259.5},{"date":"2022-09-09","current":-14.056299,"twenty":-26.91783,"median":-9.945501,"eighty":-2.390395,"marketCap":64720708.18},{"date":"2022-09-16","current":-15.123865,"twenty":-26.91783,"median":-9.945501,"eighty":-2.614263,"marketCap":68691283.84},{"date":"2022-09-23","current":-14.234226,"twenty":-26.91783,"median":-9.945501,"eighty":-2.677242,"marketCap":61880656.83},{"date":"2022-09-30","current":-12.988732,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":57552095.43},{"date":"2022-10-07","current":-11.565309,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":51142438.53},{"date":"2022-10-14","current":-11.565309,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":51585883.34},{"date":"2022-10-21","current":-12.454948,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":55512308.19},{"date":"2022-10-28","current":-11.565309,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":53294413.16},{"date":"2022-11-04","current":-10.67567,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":47949593.94},{"date":"2022-11-11","current":-9.78603,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":45795805.68},{"date":"2022-11-18","current":-9.430175,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":44703422.62},{"date":"2022-11-25","current":-10.67567,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":51312342.41},{"date":"2022-12-02","current":-9.78603,"twenty":-26.91783,"median":-9.945501,"eighty":-2.714148,"marketCap":47666052.57},{"date":"2022-12-09","current":-9.78603,"twenty":-26.91783,"median":-9.78603,"eighty":-2.714148,"marketCap":47868342.91},{"date":"2022-12-16","current":-8.006752,"twenty":-26.91783,"median":-9.78603,"eighty":-2.714148,"marketCap":38691907.59},{"date":"2022-12-23","current":-9.78603,"twenty":-26.91783,"median":-9.78603,"eighty":-2.714148,"marketCap":46928536.8},{"date":"2022-12-30","current":-5.282797,"twenty":-26.91783,"median":-9.78603,"eighty":-2.714148,"marketCap":42624267.73},{"date":"2023-01-06","current":-4.754517,"twenty":-26.91783,"median":-9.78603,"eighty":-2.863241,"marketCap":38350751.03},{"date":"2023-01-13","current":-6.128044,"twenty":-26.91783,"median":-9.78603,"eighty":-2.900587,"marketCap":50081369.07},{"date":"2023-01-20","current":-5.811076,"twenty":-26.91783,"median":-9.78603,"eighty":-2.96409,"marketCap":48178895.37},{"date":"2023-01-27","current":-5.705421,"twenty":-26.91783,"median":-9.78603,"eighty":-2.98773,"marketCap":47304672.76},{"date":"2023-02-03","current":-6.2337,"twenty":-26.91783,"median":-9.78603,"eighty":-2.98773,"marketCap":50487038.29},{"date":"2023-02-10","current":-6.445012,"twenty":-26.91783,"median":-9.78603,"eighty":-3.049974,"marketCap":52086959.78},{"date":"2023-02-17","current":-11.428401,"twenty":-26.91783,"median":-9.78603,"eighty":-3.112218,"marketCap":91807447.31},{"date":"2023-02-24","current":-7.407297,"twenty":-26.91783,"median":-9.78603,"eighty":-3.112218,"marketCap":59258151.15},{"date":"2023-03-03","current":-6.391439,"twenty":-26.91783,"median":-9.78603,"eighty":-3.112218,"marketCap":51264830.87},{"date":"2023-03-10","current":-6.45493,"twenty":-26.91783,"median":-9.78603,"eighty":-3.155321,"marketCap":52132508.38},{"date":"2023-03-17","current":-6.81208,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":55519867.82},{"date":"2023-03-24","current":-4.582672,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":37515932.96},{"date":"2023-03-31","current":-5.078096,"twenty":-26.902555,"median":-9.78603,"eighty":-3.250937,"marketCap":42069035.78},{"date":"2023-04-06","current":-4.33496,"twenty":-26.902555,"median":-9.78603,"eighty":-3.250937,"marketCap":36093433.8},{"date":"2023-04-14","current":-3.839536,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":32199878.52},{"date":"2023-04-21","current":-3.839536,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":32012252.7},{"date":"2023-04-28","current":-4.211104,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":35228639.42},{"date":"2023-05-05","current":-4.95424,"twenty":-26.91783,"median":-9.78603,"eighty":-3.250937,"marketCap":41687101.52},{"date":"2023-05-12","current":-0.078124,"twenty":-26.990461,"median":-9.78603,"eighty":-3.298952,"marketCap":654641.81},{"date":"2023-05-19","current":-3.467968,"twenty":-26.990461,"median":-9.78603,"eighty":-3.298952,"marketCap":28826717.64},{"date":"2023-05-26","current":-3.507829,"twenty":-26.990461,"median":-9.78603,"eighty":-3.298952,"marketCap":28953912},{"date":"2023-06-02","current":-3.997814,"twenty":-26.990461,"median":-9.78603,"eighty":-3.298952,"marketCap":33525582},{"date":"2023-06-09","current":-4.405629,"twenty":-26.990461,"median":-9.78603,"eighty":-3.346553,"marketCap":37021536},{"date":"2023-06-16","current":-3.867639,"twenty":-26.990461,"median":-9.78603,"eighty":-3.355339,"marketCap":33048107},{"date":"2023-06-23","current":-3.62005,"twenty":-27.003864,"median":-9.78603,"eighty":-3.42344,"marketCap":30878926},{"date":"2023-06-30","current":-3.504633,"twenty":-27.017266,"median":-9.78603,"eighty":-3.485684,"marketCap":29602937},{"date":"2023-07-07","current":-3.513265,"twenty":-27.017266,"median":-9.78603,"eighty":-3.485684,"marketCap":29858135},{"date":"2023-07-14","current":-3.133612,"twenty":-27.017266,"median":-9.78603,"eighty":-3.485684,"marketCap":27484796},{"date":"2023-07-21","current":-3.618398,"twenty":-27.017266,"median":-9.78603,"eighty":-3.508916,"marketCap":31134124},{"date":"2023-07-28","current":-5.570448,"twenty":-27.017266,"median":-9.78603,"eighty":-3.585592,"marketCap":47977175},{"date":"2023-08-04","current":-4.74099,"twenty":-27.017266,"median":-9.78603,"eighty":-3.585592,"marketCap":40374172},{"date":"2023-08-11","current":-3.747015,"twenty":-27.017266,"median":-9.78603,"eighty":-3.59396,"marketCap":31941592},{"date":"2023-08-18","current":-4.640029,"twenty":-27.017266,"median":-9.78603,"eighty":-3.659792,"marketCap":39607574},{"date":"2023-08-25","current":-2.990794,"twenty":-27.017266,"median":-9.78603,"eighty":-3.659792,"marketCap":50148300},{"date":"2023-09-01","current":-3.053779,"twenty":-27.017266,"median":-9.78603,"eighty":-3.672418,"marketCap":51362080},{"date":"2023-09-07","current":-3.057074,"twenty":-27.017266,"median":-9.78603,"eighty":-3.672418,"marketCap":50595482},{"date":"2023-09-15","current":-2.746027,"twenty":-27.039861,"median":-9.78603,"eighty":-3.682592,"marketCap":45229294},{"date":"2023-09-22","current":-3.363611,"twenty":-27.039861,"median":-9.78603,"eighty":-3.682592,"marketCap":54887791},{"date":"2023-09-29","current":-3.257767,"twenty":-27.039861,"median":-9.78603,"eighty":-3.682592,"marketCap":52771295},{"date":"2023-10-06","current":-4.371516,"twenty":-27.058244,"median":-9.78603,"eighty":-3.734662,"marketCap":70549860},{"date":"2023-10-12","current":-3.029811,"twenty":-27.067435,"median":-9.78603,"eighty":-3.734662,"marketCap":49102702},{"date":"2023-10-20","current":-2.801444,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":45151910},{"date":"2023-10-27","current":-2.845109,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":45716309},{"date":"2023-11-03","current":-3.277386,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":52959825},{"date":"2023-11-10","current":-3.509737,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":57209687},{"date":"2023-11-17","current":-3.352312,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":55248212},{"date":"2023-11-24","current":-3.243542,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":53940562},{"date":"2023-12-01","current":-4.015069,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":53286737},{"date":"2023-12-08","current":-4.187496,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":55575125},{"date":"2023-12-15","current":-4.162863,"twenty":-27.076627,"median":-9.78603,"eighty":-3.734662,"marketCap":55248212},{"date":"2023-12-22","current":-4.307366,"twenty":-27.076627,"median":-9.78603,"eighty":-3.73832,"marketCap":57166006},{"date":"2023-12-29","current":-4.733094,"twenty":-27.076627,"median":-9.78603,"eighty":-3.750951,"marketCap":62816134},{"date":"2024-01-05","current":-4.25728,"twenty":-27.076627,"median":-9.78603,"eighty":-3.799302,"marketCap":56501285},{"date":"2024-01-12","current":-4.232238,"twenty":-27.076627,"median":-9.78603,"eighty":-3.824632,"marketCap":56168924},{"date":"2024-01-19","current":-4.182152,"twenty":-27.076627,"median":-9.78603,"eighty":-3.824632,"marketCap":55504203},{"date":"2024-01-26","current":-3.956767,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":52512959},{"date":"2024-02-02","current":-3.731381,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":49521714},{"date":"2024-02-09","current":-3.581124,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":47527551},{"date":"2024-02-16","current":-3.505996,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":46530470},{"date":"2024-02-23","current":-3.73664,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":49591510},{"date":"2024-03-01","current":-3.330696,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":44203946},{"date":"2024-03-08","current":-3.531289,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":46866154},{"date":"2024-03-15","current":-3.556081,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":47195191},{"date":"2024-03-22","current":-4.407537,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":58495448},{"date":"2024-03-28","current":-3.756424,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839937,"marketCap":49854075},{"date":"2024-04-05","current":-3.756424,"twenty":-27.076627,"median":-9.78603,"eighty":-3.841539,"marketCap":49854075},{"date":"2024-04-12","current":-3.405824,"twenty":-27.076627,"median":-9.78603,"eighty":-3.841539,"marketCap":45201028},{"date":"2024-04-19","current":-3.669525,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":48700784},{"date":"2024-04-26","current":-3.622946,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":48082593},{"date":"2024-05-03","current":-3.869117,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":51349697},{"date":"2024-05-10","current":-3.781467,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":50186435},{"date":"2024-05-17","current":-3.881638,"twenty":-27.076627,"median":-9.78603,"eighty":-3.839536,"marketCap":51515877},{"date":"2024-05-24","current":-3.716606,"twenty":-27.076627,"median":-9.78603,"eighty":-3.824632,"marketCap":49325621},{"date":"2024-05-31","current":-3.481203,"twenty":-27.076627,"median":-9.78603,"eighty":-3.807241,"marketCap":46201433},{"date":"2024-06-07","current":-3.355739,"twenty":-27.076627,"median":-9.78603,"eighty":-3.78464,"marketCap":44536307},{"date":"2024-06-14","current":-3.406075,"twenty":-27.076627,"median":-9.78603,"eighty":-3.756424,"marketCap":45204351},{"date":"2024-06-21","current":-3.10531,"twenty":-27.076627,"median":-9.78603,"eighty":-3.754542,"marketCap":41212702},{"date":"2024-06-28","current":-2.831843,"twenty":-27.076627,"median":-9.78603,"eighty":-3.737141,"marketCap":37583325},{"date":"2024-07-05","current":-2.955053,"twenty":-27.076627,"median":-9.78603,"eighty":-3.731381,"marketCap":39218539},{"date":"2024-07-12","current":-3.681295,"twenty":-27.076627,"median":-9.78603,"eighty":-3.706338,"marketCap":48856993},{"date":"2024-07-15","current":-3.981809,"twenty":-27.076627,"median":-9.78603,"eighty":-3.706338,"marketCap":52845319},{"date":"2024-08-02","current":-2.491761,"twenty":-27.076627,"median":-9.945501,"eighty":-3.693817,"marketCap":33069869},{"date":"2024-08-09","current":-2.47924,"twenty":-27.076627,"median":-9.945501,"eighty":-3.681295,"marketCap":32903689},{"date":"2024-08-16","current":-1.936033,"twenty":-27.076627,"median":-9.945501,"eighty":-3.676587,"marketCap":32574652},{"date":"2024-08-23","current":-2.091459,"twenty":-27.076627,"median":-9.78603,"eighty":-3.656253,"marketCap":35189768},{"date":"2024-08-30","current":-2.674655,"twenty":-27.076627,"median":-9.78603,"eighty":-3.642585,"marketCap":45002300},{"date":"2024-09-06","current":-2.11157,"twenty":-27.076627,"median":-9.78603,"eighty":-3.627904,"marketCap":35528131},{"date":"2024-09-13","current":-2.081404,"twenty":-27.076627,"median":-9.78603,"eighty":-3.606167,"marketCap":35020587},{"date":"2024-09-20","current":-2.051239,"twenty":-27.076627,"median":-9.78603,"eighty":-3.588711,"marketCap":34513042},{"date":"2024-09-27","current":-2.011019,"twenty":-27.076627,"median":-9.78603,"eighty":-3.585592,"marketCap":33836316},{"date":"2024-10-04","current":-2.071349,"twenty":-27.076627,"median":-9.78603,"eighty":-3.585592,"marketCap":34851405},{"date":"2024-10-11","current":-2.011019,"twenty":-27.076627,"median":-9.78603,"eighty":-3.580106,"marketCap":33836316},{"date":"2024-10-18","current":-2.031129,"twenty":-27.076627,"median":-9.78603,"eighty":-3.540898,"marketCap":34174679},{"date":"2024-10-25","current":-2.21212,"twenty":-27.076627,"median":-9.78603,"eighty":-3.531038,"marketCap":37219947},{"date":"2024-10-31","current":-2.342837,"twenty":-27.076627,"median":-9.78603,"eighty":-3.509737,"marketCap":39419308},{"date":"2024-11-08","current":-2.272451,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":38235037},{"date":"2024-11-15","current":-2.131881,"twenty":-27.076627,"median":-9.78603,"eighty":-3.477134,"marketCap":35869878},{"date":"2024-11-22","current":-2.15179,"twenty":-27.076627,"median":-9.78603,"eighty":-3.458705,"marketCap":36204858},{"date":"2024-11-29","current":-2.054054,"twenty":-27.076627,"median":-9.78603,"eighty":-3.453872,"marketCap":34560413},{"date":"2024-12-06","current":-2.035151,"twenty":-27.076627,"median":-9.78603,"eighty":-3.4105,"marketCap":34242351},{"date":"2024-12-13","current":-2.13168,"twenty":-27.076627,"median":-9.78603,"eighty":-3.401864,"marketCap":35866494},{"date":"2024-12-20","current":-2.19201,"twenty":-27.076627,"median":-9.78603,"eighty":-3.401864,"marketCap":36881584},{"date":"2024-12-27","current":-2.15179,"twenty":-27.076627,"median":-9.78603,"eighty":-3.401864,"marketCap":36204858},{"date":"2025-01-03","current":-2.272451,"twenty":-27.076627,"median":-9.78603,"eighty":-3.401864,"marketCap":38235037},{"date":"2025-01-10","current":-2.584159,"twenty":-27.076627,"median":-9.78603,"eighty":-3.403621,"marketCap":43479666},{"date":"2025-01-17","current":-2.101514,"twenty":-27.076627,"median":-9.78603,"eighty":-3.401462,"marketCap":35358950},{"date":"2025-01-24","current":-2.081404,"twenty":-27.076627,"median":-9.78603,"eighty":-3.363473,"marketCap":35020587},{"date":"2025-01-31","current":-2.218676,"twenty":-27.076627,"median":-9.78603,"eighty":-3.352312,"marketCap":37330240},{"date":"2025-02-07","current":-3.605806,"twenty":-27.076627,"median":-9.78603,"eighty":-3.358188,"marketCap":38538382},{"date":"2025-02-14","current":-3.381633,"twenty":-27.076627,"median":-9.78603,"eighty":-3.368762,"marketCap":36142459},{"date":"2025-02-21","current":-3.461015,"twenty":-27.076627,"median":-9.78603,"eighty":-3.403621,"marketCap":36990874},{"date":"2025-02-28","current":-3.651529,"twenty":-27.076627,"median":-9.78603,"eighty":-3.41421,"marketCap":39027069},{"date":"2025-03-07","current":-4.350083,"twenty":-27.076627,"median":-9.78603,"eighty":-3.453209,"marketCap":46493117},{"date":"2025-03-14","current":-4.731112,"twenty":-27.076627,"median":-9.78603,"eighty":-3.458726,"marketCap":50565507},{"date":"2025-03-21","current":-4.000806,"twenty":-27.076627,"median":-9.78603,"eighty":-3.467968,"marketCap":42760093},{"date":"2025-03-28","current":-4.540597,"twenty":-27.076627,"median":-9.78603,"eighty":-3.474421,"marketCap":48529312},{"date":"2025-04-04","current":-3.8938,"twenty":-27.076627,"median":-9.78603,"eighty":-3.504633,"marketCap":41616430},{"date":"2025-04-11","current":-3.39751,"twenty":-27.076627,"median":-9.78603,"eighty":-3.504906,"marketCap":36312142},{"date":"2025-04-17","current":-3.587707,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":38344944},{"date":"2025-04-25","current":-4.800015,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":51301931},{"date":"2025-05-02","current":-4.969255,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":53110750},{"date":"2025-05-09","current":-4.699359,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":50226141},{"date":"2025-05-16","current":-4.413587,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":47171848},{"date":"2025-05-23","current":-5.842447,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":62443310},{"date":"2025-05-30","current":-5.937704,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":63461408},{"date":"2025-06-06","current":-5.905952,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":63122042},{"date":"2025-06-13","current":-8.033364,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":85859552},{"date":"2025-06-20","current":-7.878526,"twenty":-27.076627,"median":-9.78603,"eighty":-3.505996,"marketCap":84204663},{"date":"2025-06-27","current":-8.4913,"twenty":-27.076627,"median":-9.583846,"eighty":-3.505996,"marketCap":90753915},{"date":"2025-07-03","current":-9.734357,"twenty":-27.076627,"median":-9.430175,"eighty":-3.505996,"marketCap":104039540},{"date":"2025-07-11","current":-10.014482,"twenty":-27.076627,"median":-9.430175,"eighty":-3.505996,"marketCap":107033483},{"date":"2025-07-18","current":-10.154545,"twenty":-27.076627,"median":-9.403019,"eighty":-3.505996,"marketCap":108530455},{"date":"2025-07-25","current":-22.056741,"twenty":-27.076627,"median":-9.403019,"eighty":-3.505996,"marketCap":103805465},{"date":"2025-08-01","current":-21.577247,"twenty":-27.076627,"median":-9.403019,"eighty":-3.505996,"marketCap":101548825},{"date":"2025-08-08","current":-25.253371,"twenty":-26.738278,"median":-9.403019,"eighty":-3.505996,"marketCap":118849736},{"date":"2025-08-15","current":-21.097753,"twenty":-26.371385,"median":-9.403019,"eighty":-3.505996,"marketCap":99292184},{"date":"2025-08-22","current":-18.620365,"twenty":-26.345185,"median":-9.403019,"eighty":-3.505996,"marketCap":87632875},{"date":"2025-08-29","current":-18.180828,"twenty":-26.129892,"median":-9.403019,"eighty":-3.505996,"marketCap":85564287},{"date":"2025-09-05","current":-17.981039,"twenty":-26.129892,"median":-9.403019,"eighty":-3.505996,"marketCap":84624021},{"date":"2025-09-12","current":-17.341713,"twenty":-25.7121,"median":-9.403019,"eighty":-3.505996,"marketCap":81615166},{"date":"2025-09-19","current":-16.542556,"twenty":-25.378999,"median":-9.403019,"eighty":-3.505996,"marketCap":77854099},{"date":"2025-09-26","current":-17.741292,"twenty":-25.183157,"median":-9.403019,"eighty":-3.505996,"marketCap":83495700},{"date":"2025-10-03","current":-15.823314,"twenty":-25.183157,"median":-9.403019,"eighty":-3.505996,"marketCap":74469138},{"date":"2025-10-10","current":-16.782303,"twenty":-25.183157,"median":-9.403019,"eighty":-3.505996,"marketCap":78982419},{"date":"2025-10-17","current":-16.862219,"twenty":-24.830312,"median":-9.403019,"eighty":-3.505996,"marketCap":79358526},{"date":"2025-10-24","current":-17.901123,"twenty":-24.588839,"median":-9.403019,"eighty":-3.505996,"marketCap":84247914},{"date":"2025-10-31","current":-20.77809,"twenty":-24.588839,"median":-9.403019,"eighty":-3.505996,"marketCap":97787757},{"date":"2025-11-07","current":-21.017837,"twenty":-24.588839,"median":-9.403019,"eighty":-3.505996,"marketCap":98916077},{"date":"2025-11-14","current":-19.099859,"twenty":-24.588839,"median":-9.403019,"eighty":-3.505996,"marketCap":89889515},{"date":"2025-11-21","current":-15.263904,"twenty":-24.588839,"median":-9.403019,"eighty":-3.505996,"marketCap":71836391},{"date":"2025-11-28","current":-15.663483,"twenty":-24.588839,"median":-9.403019,"eighty":-3.505996,"marketCap":73716924},{"date":"2025-12-05","current":-16.063062,"twenty":-24.03361,"median":-9.403019,"eighty":-3.505996,"marketCap":75597458},{"date":"2025-12-12","current":-17.261798,"twenty":-23.66838,"median":-9.403019,"eighty":-3.505996,"marketCap":81239060},{"date":"2025-12-19","current":-14.944241,"twenty":-23.539714,"median":-9.403019,"eighty":-3.505996,"marketCap":70331964},{"date":"2025-12-26","current":-16.222893,"twenty":-22.832494,"median":-9.403019,"eighty":-3.505996,"marketCap":76349672},{"date":"2026-01-02","current":-16.542556,"twenty":-22.098835,"median":-9.403019,"eighty":-3.505996,"marketCap":77854099},{"date":"2026-01-09","current":-18.540449,"twenty":-21.908392,"median":-9.403019,"eighty":-3.505996,"marketCap":87256768},{"date":"2026-01-16","current":-19.099859,"twenty":-21.832338,"median":-9.403019,"eighty":-3.505996,"marketCap":89889515},{"date":"2026-01-23","current":-18.940028,"twenty":-21.577247,"median":-9.403019,"eighty":-3.505996,"marketCap":89137302},{"date":"2026-01-30","current":-16.302809,"twenty":-21.515234,"median":-9.403019,"eighty":-3.505996,"marketCap":76725779},{"date":"2026-02-06","current":-16.702618,"twenty":-21.515234,"median":-9.403019,"eighty":-3.505996,"marketCap":77054874},{"date":"2026-02-13","current":-24.163253,"twenty":-21.515234,"median":-9.403019,"eighty":-3.505996,"marketCap":111473327},{"date":"2026-02-20","current":-19.597846,"twenty":-21.515234,"median":-9.403019,"eighty":-3.505996,"marketCap":90411546},{"date":"2026-02-27","current":-19.15244,"twenty":-21.515234,"median":-9.403019,"eighty":-3.505996,"marketCap":88356738},{"date":"2026-03-06","current":-18.818386,"twenty":-21.500912,"median":-9.403019,"eighty":-3.505996,"marketCap":86815632},{"date":"2026-03-13","current":-18.929737,"twenty":-21.183508,"median":-9.403019,"eighty":-3.505996,"marketCap":87329334},{"date":"2026-03-20","current":-18.428379,"twenty":-20.77809,"median":-9.403019,"eighty":-3.505996,"marketCap":85016396},{"date":"2026-03-27","current":-17.973357,"twenty":-20.638827,"median":-9.403019,"eighty":-3.505996,"marketCap":82917226},{"date":"2026-04-02","current":-18.883401,"twenty":-20.410477,"median":-9.403019,"eighty":-3.505996,"marketCap":87115566},{"date":"2026-04-10","current":-17.973357,"twenty":-19.916921,"median":-9.403019,"eighty":-3.505996,"marketCap":82917226},{"date":"2026-04-17","current":-18.087113,"twenty":-19.846956,"median":-9.403019,"eighty":-3.505996,"marketCap":83442018},{"date":"2026-04-24","current":-18.087113,"twenty":-19.583052,"median":-9.403019,"eighty":-3.505996,"marketCap":83442018},{"date":"2026-05-01","current":-17.745846,"twenty":-19.489744,"median":-9.403019,"eighty":-3.505996,"marketCap":81867640},{"date":"2026-05-08","current":-18.428379,"twenty":-19.233329,"median":-9.403019,"eighty":-3.505996,"marketCap":85016396},{"date":"2026-05-15","current":-18.314623,"twenty":-19.110911,"median":-9.403019,"eighty":-3.505996,"marketCap":84491603},{"date":"2026-05-22","current":-19.110911,"twenty":-19.099859,"median":-9.403019,"eighty":-3.505996,"marketCap":88165151},{"date":"2026-05-29","current":-19.452178,"twenty":-19.064597,"median":-9.403019,"eighty":-3.505996,"marketCap":89739529},{"date":"2026-06-05","current":-19.110911,"twenty":-19.052843,"median":-9.403019,"eighty":-3.505996,"marketCap":88165151},{"date":"2026-06-12","current":-17.632091,"twenty":-18.931795,"median":-9.403019,"eighty":-3.505996,"marketCap":81342848},{"date":"2026-06-18","current":-17.859602,"twenty":-18.929737,"median":-9.403019,"eighty":-3.505996,"marketCap":82392433},{"date":"2026-06-26","current":-17.518335,"twenty":-18.883401,"median":-9.403019,"eighty":-3.505996,"marketCap":80818055},{"date":"2026-07-02","current":-17.063314,"twenty":-18.769645,"median":-9.403019,"eighty":-3.505996,"marketCap":78718885},{"date":"2026-07-10","current":-19.110911,"twenty":-18.680077,"median":-9.403019,"eighty":-3.505996,"marketCap":88165151},{"date":"2026-07-17","current":-15.698249,"twenty":-18.55601,"median":-9.403019,"eighty":-3.505996,"marketCap":72421374},{"date":"2026-07-24","current":-8.678511,"twenty":-18.55601,"median":-9.252247,"eighty":-3.505996,"marketCap":77669699},{"date":"2026-07-31","current":-9.734006,"twenty":-18.55601,"median":-9.252247,"eighty":-3.505996,"marketCap":87116014},{"date":"2026-08-07","current":-9.001024,"twenty":-18.542134,"median":-9.13909,"eighty":-3.505996,"marketCap":80556073},{"date":"2026-08-14","current":-8.854427,"twenty":-18.484332,"median":-9.074319,"eighty":-3.505996,"marketCap":79244085},{"date":"2026-08-21","current":-8.913066,"twenty":-18.428379,"median":-8.913066,"eighty":-3.505996,"marketCap":79768881}],"updateTime":1787594067719},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OKYO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649993505","title":"Okyo Pharma receives feedback from FDA Type D meeting on urcosimod pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2649993505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649993505?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:30","pubTimestamp":1783510242,"startTime":"0","endTime":"0","summary":"Okyo Pharma (OKYO) announced feedback from its FDA Type D meeting, validating the company’s regulatory and clinical path forward for urcosimod and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/okyo-pharma-receives-feedback-from-fda-type-d-meeting-on-urcosimod-pathway-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/okyo-pharma-receives-feedback-from-fda-type-d-meeting-on-urcosimod-pathway-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","OKYO","BK4139","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649296008","title":"OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2649296008","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649296008?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:00","pubTimestamp":1783508400,"startTime":"0","endTime":"0","summary":"FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the Company's clinical development program for urcosimodCompany unveils NEPTUNE ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3323947/0/en/OKYO-Pharma-Reports-Positive-Feedback-from-FDA-Type-D-Meeting-and-Accelerates-Urcosimod-into-Global-Phase-3-Pivotal-Trial-for-Neuropathic-Corneal-Pain.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","OKYO","LABU","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649648984","title":"OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2649648984","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649648984?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:00","pubTimestamp":1783422000,"startTime":"0","endTime":"0","summary":"LONDON and NEW YORK, July  07, 2026  (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neurop","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/07/3323040/0/en/OKYO-Pharma-to-Participate-in-a-Fireside-Chat-at-Piper-Sandler-2026-Virtual-Ophthalmology-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OKYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644729719","title":"OKYO Pharma files Form 3 initial beneficial ownership for CMO Flavio Mantelli","url":"https://stock-news.laohu8.com/highlight/detail?id=2644729719","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644729719?lang=en_us&edition=fundamental","pubTime":"2026-06-18 04:15","pubTimestamp":1781727354,"startTime":"0","endTime":"0","summary":"OKYO Pharma Chief Medical Officer Flavio Mantelli reported direct holdings of options for 750,000 common shares at an exercise price of $1.96.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OKYO Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL27xFmf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKYO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640921195","title":"OKYO Pharma files Form 3 as director Bernard Denoyer reports beneficial ownership holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2640921195","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640921195?lang=en_us&edition=fundamental","pubTime":"2026-06-03 07:28","pubTimestamp":1780442931,"startTime":"0","endTime":"0","summary":"OKYO Pharma director Bernard Denoyer reported holding stock options for 31,890 common shares, with exercise prices spanning $1.46 to $2.13.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OKYO Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDLcbJFh2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OKYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640960182","title":"OKYO Pharma files Form 3 for director John P. Brancaccio initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2640960182","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640960182?lang=en_us&edition=fundamental","pubTime":"2026-06-02 06:45","pubTimestamp":1780353936,"startTime":"0","endTime":"0","summary":"OKYO Pharma director John P. Brancaccio reported 30,201 common shares, including stock options for 114,864 shares at $1.46-$2.13.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OKYO Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL2PqGJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OKYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637344324","title":"OKYO Pharma files Form 3 for CEO, director Robert Dempsey beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2637344324","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637344324?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:17","pubTimestamp":1779481024,"startTime":"0","endTime":"0","summary":"OKYO Pharma CEO Robert John Dempsey filed an initial Form 3 disclosing options for 1.6 million common shares exercisable at $2.23, expiring Jan. 2, 2036.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OKYO Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDLb7CSKj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OKYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636853742","title":"OKYO Pharma Adds European Eye Disease Expert to Advisory Board as Urcosimod Advances in Neuropathic Corneal Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2636853742","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636853742?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:32","pubTimestamp":1779190335,"startTime":"0","endTime":"0","summary":"OKYO Pharma Limited Sponsored ADR ( ($OKYO) ) has provided an update. On May 19, 2026, OKYO Pharma announced it has expanded its Scientific Advisor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/okyo-pharma-adds-european-eye-disease-expert-to-advisory-board-as-urcosimod-advances-in-neuropathic-corneal-pain?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/okyo-pharma-adds-european-eye-disease-expert-to-advisory-board-as-urcosimod-advances-in-neuropathic-corneal-pain?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKYO","EPV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636385892","title":"OKYO Pharma appoints Marta Sacchetti to scientific advisory board","url":"https://stock-news.laohu8.com/highlight/detail?id=2636385892","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636385892?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:02","pubTimestamp":1779188538,"startTime":"0","endTime":"0","summary":"Sacchetti is an associate professor of ophthalmology at Link University in Rome.She previously served as global head of clinical development for ophthalmology and neurotrophins at Dompé Farmaceutici.The company is developing urcosimod for neuropathic corneal pain, an investigational therapy with FDA Fast Track designation.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL62vTwj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4139","SG9999014013.SGD","LU2095319765.USD","BK4585","SG9999014021.USD","LU0314104364.USD","BK4112","SG9999014005.SGD","LU2210150020.SGD","SG9999014039.USD","IE00BN0W2W23.USD","NDAQ","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4588","IE00B64PRP62.GBP","OKYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636858641","title":"Press Release: OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD","url":"https://stock-news.laohu8.com/highlight/detail?id=2636858641","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636858641?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:00","pubTimestamp":1779188400,"startTime":"0","endTime":"0","summary":"-- Dr. Sacchetti brings international expertise in clinical and. translational research on ocular inflammatory and degenerative disease. -- OKYO's introduction to the broader ophthalmology community at ASCRS drove. LONDON and NEW YORK, May 19, 2026  -- OKYO Pharma Limited , a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain  and for inflammatory eye diseases, today announced the expansion of their Scientific Advisory Board  with the appointment of Marta Sacchetti, MD, PhD. This appointment further enhances the Company's global scientific network with premier European specialists.\"Our world class Scientific Advisory Board is further strengthened by the addition of Marta Sacchetti, MD, PhD,\" said Flavio Mantelli, MD, PhD, Chief Medical Officer of OKYO Pharma. \"Her expertise in neuro-inflammatory corneal diseases brings critical insight into addressing the underlying nerve dysfunction driving neuropathic corneal pa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4139","OKYO","MD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631590178","title":"OKYO Pharma CEO to present at Eyecelerator conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2631590178","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631590178?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:01","pubTimestamp":1777460474,"startTime":"0","endTime":"0","summary":"OKYO Pharma CEO Robert Dempsey is scheduled to present at Eyecelerator in Denver on May 1, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL3TpK3Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4139","SG9999014013.SGD","LU2095319765.USD","BK4585","SG9999014021.USD","LU0314104364.USD","BK4112","SG9999014005.SGD","LU2210150020.SGD","SG9999014039.USD","IE00BN0W2W23.USD","NDAQ","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4588","IE00B64PRP62.GBP","OKYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625937439","title":"OKYO Pharma to Showcase Urcosimod Data and Convene Key Advisory Board at 2026 ASCRS Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2625937439","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625937439?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:33","pubTimestamp":1775561605,"startTime":"0","endTime":"0","summary":"An announcement from OKYO Pharma Limited Sponsored ADR ( ($OKYO) ) is now available. On April 7, 2026, OKYO Pharma announced it will convene a key ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/okyo-pharma-to-showcase-urcosimod-data-and-convene-key-advisory-board-at-2026-ascrs-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/okyo-pharma-to-showcase-urcosimod-data-and-convene-key-advisory-board-at-2026-ascrs-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OKYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625893258","title":"OKYO Pharma plans new urcosimod trial for neuropathic corneal pain in H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2625893258","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625893258?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:01","pubTimestamp":1775559669,"startTime":"0","endTime":"0","summary":"OKYO Pharma scheduled a Scientific Advisory Board meeting during 2026 ASCRS Annual Meeting to review clinical data for lead candidate urcosimod and shape next-stage development plans.Phase 2 proof-of-concept results in neuropathic corneal pain were described as showing encouraging efficacy signals with a favorable safety profile.OKYO plans to initiate next urcosimod clinical trial in first half of 2026, supported by FDA Fast Track status for neuropathic corneal pain.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OKYO Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL3DBmFg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OKYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620221666","title":"OKYO Pharma Director Boosts Stake as Lead Eye-Pain Drug Advances Toward Phase 2b/3","url":"https://stock-news.laohu8.com/highlight/detail?id=2620221666","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620221666?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:28","pubTimestamp":1773930503,"startTime":"0","endTime":"0","summary":"OKYO Pharma Limited Sponsored ADR ( ($OKYO) ) just unveiled an announcement. On March 19, 2026, OKYO Pharma announced that non-executive director J...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/okyo-pharma-director-boosts-stake-as-lead-eye-pain-drug-advances-toward-phase-2b-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/okyo-pharma-director-boosts-stake-as-lead-eye-pain-drug-advances-toward-phase-2b-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKYO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620267202","title":"OKYO Pharma director John Brancaccio buys 5,000 shares at USD 1.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2620267202","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620267202?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:01","pubTimestamp":1773928862,"startTime":"0","endTime":"0","summary":"Non-Executive Director John Brancaccio bought 5,000 OKYO ordinary shares on Nasdaq at USD 1.61.The purchase increased his total holding to 31,201 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OKYO Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDLDxnYt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"OKYO Pharma director John Brancaccio buys 5,000 shares at USD 1.61","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKYO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620024219","title":"Okyo Pharma CDO, director acquire shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620024219","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620024219?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:37","pubTimestamp":1773920229,"startTime":"0","endTime":"0","summary":"OKYO Pharma (OKYO) announced it has been informed that Gary Jacob, Chief Development Officer and Director, has acquired 30,980 of the Company’s ord...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/okyo-pharma-cdo-director-acquire-shares-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/okyo-pharma-cdo-director-acquire-shares-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKYO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620632228","title":"OKYO Pharma Announces Chief Development Officer and Director Acquires Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2620632228","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620632228?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:00","pubTimestamp":1773918000,"startTime":"0","endTime":"0","summary":"LONDON and NEW YORK, March  19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neurop","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3258842/0/en/OKYO-Pharma-Announces-Chief-Development-Officer-and-Director-Acquires-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OKYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620291668","title":"OKYO Pharma Chief Development Officer Gary S. Jacob files Form 3 initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620291668","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620291668?lang=en_us&edition=fundamental","pubTime":"2026-03-19 08:38","pubTimestamp":1773880710,"startTime":"0","endTime":"0","summary":"OKYO Pharma reported an initial statement of beneficial ownership for Gary Jacob, a director and Chief Development Officer. The filing shows he beneficially owned 108,920 shares of common stock. It also lists stock options exercisable for 21,154 shares at a USD 2.13 exercise price. Additional options are shown exercisable for 102,653 shares at a USD 1.6 exercise price.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OKYO Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL10lFXn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OKYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620291503","title":"OKYO Pharma Director and 10% Owner Gabriele M Cerrone Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620291503","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620291503?lang=en_us&edition=fundamental","pubTime":"2026-03-19 08:36","pubTimestamp":1773880588,"startTime":"0","endTime":"0","summary":"OKYO Pharma reported an initial statement of beneficial ownership by director and 10% owner Gabriele Cerrone. Cerrone reported direct beneficial ownership of 10.53 million shares of common stock. The date of the event requiring the statement was March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OKYO Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL9s0Bvg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OKYO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620588452","title":"Okyo Pharma reports results from Phase 2a trial of urcosimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2620588452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620588452?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:22","pubTimestamp":1773832972,"startTime":"0","endTime":"0","summary":"OKYO Pharma (OKYO) announced new positive findings from an exploratory analysis of patient-reported outcomes in its recently completed Phase 2a tri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/okyo-pharma-reports-results-from-phase-2a-trial-of-urcosimod-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/okyo-pharma-reports-results-from-phase-2a-trial-of-urcosimod-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OKYO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}]}}